Regulatory sunlight for insurance brokers

Insurance brokerags have reached agreements in the US allowing them to take contingent commissions, a practice that had been banned since 2005

Bill Bergman 18 February, 2010 | 9:57AM
Facebook Twitter LinkedIn

News came this week that the largest publicly traded insurance brokerage organisations--Marsh & McLennan Companies, Aon, and Willis Group--have reached "restated agreements" with various US state regulatory authorities allowing them to take contingent commissions, a practice that had been banned since 2005. This news follows on the heels of Arthur J. Gallagher's 2009 agreement winning over Illinois authorities to that position. We've been expecting some rationalisation of regulatory practice along these lines.

Contingent commissions compensate brokers for the profit and/or volume of business placed with an insurance company. On the face of it, these arrangements can clearly be abused. But they originated as a market incentive for brokers to take a stake in controlling losses facing insurers and can also work to align the interests of clients, intermediaries, and insurance companies.

The 2005 agreements led to a skewed market outcome as the vast majority of the intermediaries in this fragmented market were allowed to keep taking contingents while the larger firms were operating under the bans. Over time, insurance companies developed alternative ways of rewarding (or penalising) firms operating under the ban, including base commission rate changes and "supplemental" commissions.

Contingent commissions still have their critics even at the larger brokers (Willis has stated it will continue to avoid taking them). But we think the recent changes should help promote economic efficiency by allowing the market a greater role in deciding what is or is not acceptable practice. In turn, it should help lift uncertainty and other weights on brokerage revenue and profitability. The new revenue won't simply be a step upward dollar for dollar, as alternative practices helped fill in some of the gap since 2005. But the regulatory headwinds are certainly fading.

The brokers have been shouldering other weights in recent years, to be sure. The slow economy has coupled with soft insurance pricing and the impact of near-zero short-term interest rates on float returns to reduce revenue growth and margins well below historic averages. We anticipated some form of rationalisation of regulatory practices relating to compensation as one element of our thesis on the brokers. This latest news helps cement those earlier expectations--a factor that could boost our fair value estimates as we update our models for 2009 results. Insurance pricing remains persistently weak, but we still don't think falling insurance rates, a contracting economy, and near-zero money market rates will be permanent.

Bill Bergman is a Morningstar equity analyst.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

Bill Bergman  Bill Bergman is a senior stock analyst with Morningstar. He served as a research associate with William Blair for five years, as an economist and senior financial markets policy analyst for the Federal Reserve Bank of Chicago for 13 years, and as an economist and director of the Summer Fellowship Program for the American Institute for Economic Research.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures